Monogram Technologies INC DEF 14A proxy statements

Monogram Technologies Inc. is reminding shareholders to vote on the proposed acquisition by Zimmer Biomet Holdings, Inc. and offering guidance on share transfers.

Monogram Technologies Inc. is actively soliciting stockholder votes for the upcoming special meeting on September 30, 2025, to approve its acquisition by Zimmer Biomet Holdings, Inc.

Monogram Technologies Inc. stockholders are invited to a special meeting on September 30, 2025, to vote on a proposed merger with Zimmer Biomet Holdings, Inc., offering $4.04 cash plus contingent value rights per common share.

Monogram Technologies Inc. and Zimmer Biomet Holdings, Inc. amended their merger agreement, specifically modifying the definition of "Permitted Transfer" in the CVR Agreement following an SEC comment.

Monogram Technologies Inc. informed stockholders via text message about updated FAQs regarding its proposed acquisition by Zimmer Biomet Holdings, Inc.

Monogram Technologies Inc. informed shareholders about a new FAQ section on its Investor Relations page providing details on the proposed acquisition by Zimmer Biomet Holdings, Inc.

Monogram Technologies Inc. announced it will be acquired by Zimmer Biomet Holdings, Inc. for $4.04 cash per share plus a Contingent Value Right.

Zimmer Biomet Holdings, Inc. has entered into a definitive agreement to acquire Monogram Technologies Inc. for an upfront cash payment of $4.04 per share, plus contingent value rights tied to future product development, regulatory, and revenue milestones.

Monogram Technologies Inc. will hold its 2024 Annual Meeting of Stockholders virtually on December 19, 2024, to vote on director elections, auditor ratification, an amendment to the stock option plan, and executive compensation.